Ian M. Gralnek, MD, MSHS
Advertisement
Articles by Ian M. Gralnek, MD, MSHS
Advertisement
Latest Updated Articles
- Budget Impact of Tegaserod on a Managed Care Organization Formulary
Published: April 15th 2005 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Inebilizumab for Generalized Myasthenia Gravis
2
Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia
3
Cardiotoxicity Remains a Concern as Breast Cancer Survival Rates Improve: Eric H. Yang, MD
4
Real-World Safety Signals of Bimekizumab Emerge in New FAERS Analysis
5
